Bedaquiline Tablets 100mg (Hamsen) PAN India Manufacturer and Global Supplier
Taj Pharma India is recognized as a premier manufacturer, supplier, and exporter of Bedaquiline Tablets 100mg (Hamsen). With world-class manufacturing facilities in Vapi, Gujarat, and a strong presence in Mumbai, Maharashtra, we ensure that our products meet the highest standards of quality, safety, and therapeutic efficacy. As a trusted name in the pharmaceutical industry, we provide PAN India distribution as well as international supply to Africa, the Middle East, and Latin America (LTAM).
Bedaquiline Tablets 100mg (Hamsen) Overview
Bedaquiline Tablets 100mg are a groundbreaking medicine used in the treatment of multidrug-resistant tuberculosis (MDR-TB). It is classified as an anti-tuberculosis antibiotic and works by inhibiting ATP synthase, an enzyme vital for the survival of Mycobacterium tuberculosis. By blocking this enzyme, Bedaquiline starves the bacteria of energy, leading to their death.
- Strength: 100mg
- Brand Name: Hamsen (by Taj Pharma)
- Formulation: Film-coated tablets
- Route of Administration: Oral
- Therapeutic Class: Anti-TB medicine
This drug is prescribed as part of a combination therapy for patients whose tuberculosis has not responded to traditional medicines such as isoniazid and rifampicin.
Leading Manufacturer & Exporter of Bedaquiline Tablets
At Taj Pharmaceuticals, we take pride in being a globally trusted Bedaquiline Tablets 100mg manufacturer and supplier from India. Our facilities comply with WHO-GMP, ISO, and international regulatory standards, ensuring our products meet stringent global quality requirements.
Why Choose Taj Pharma?
- Advanced WHO-GMP manufacturing units in Vapi, Gujarat
- Head office and major distribution from Mumbai, Maharashtra
- PAN India presence with strong export capabilities
- Competitive pricing with bulk supply options
- Trusted partner for government tenders, NGOs, and hospitals
We have established ourselves as a pioneer in anti-tuberculosis medicines, ensuring global accessibility to life-saving treatments.
Therapeutic Indications of Bedaquiline Tablets 100mg
Bedaquiline is indicated for use in:
- Pulmonary multidrug-resistant tuberculosis (MDR-TB)
- TB cases resistant to isoniazid and rifampicin
- Combination therapy regimens for advanced MDR-TB cases
It is always prescribed along with other anti-TB drugs to avoid the development of drug resistance.
Safety, Caution & Warnings
While Bedaquiline Tablets 100mg are highly effective, patients must follow medical supervision due to potential side effects.
- Heart Rhythm Issues: May cause QT prolongation, leading to irregular heartbeat. ECG monitoring is essential.
- Liver Monitoring: Can increase liver enzymes; patients require regular liver function tests.
- Drug Interactions: Should not be taken with certain other medicines that affect the heart or liver.
- Alcohol Use: Avoid alcohol during treatment to reduce side effect risks.
Possible Side Effects Include:
- Headache, nausea, dizziness
- Chest pain, palpitations
- Fainting or irregular heartbeat (rare)
Dosage & Administration
- Initial Phase (Weeks 1–2): 400mg once daily with food
- Continuation Phase (Weeks 3–24): 200mg three times per week with food
- Duration: Up to 24 weeks in combination with other anti-TB medicines
Storage: Store in a cool, dry place below 30°C, protected from light and moisture.
Technical Specification of Bedaquiline Tablets 100mg (Hamsen)
- Generic Name: Bedaquiline Tablets
- Brand Name: Hamsen
- Strength: 100mg
- Formulation: Film-coated Tablets
- Route of Administration: Oral
- Manufacturer: Taj Pharma India (Vapi, Gujarat & Mumbai, Maharashtra)
- Packing: Blister packs or bottles
- Regulatory Approvals: WHO-GMP, ISO, COA, MSDS
- Shelf Life: 24 months
- Indications: MDR-TB treatment as part of a combination regimen
Bedaquiline Tablets Manufacturer & Supplier from Mumbai and Gujarat
With major hubs in Mumbai, Maharashtra and Vapi, Gujarat, Taj Pharma offers both domestic distribution and global export. Our Bedaquiline Tablets 100mg are supplied to:
- Hospitals and Clinics across India
- Government health programs for TB eradication
- International NGOs and procurement agencies
- Pharma distributors and PCD franchise partners
We ensure timely deliveries and competitive pricing, making us the preferred Bedaquiline supplier PAN India.
Global Export of Bedaquiline Tablets 100mg
Taj Pharma India has established itself as a leading exporter of Bedaquiline Tablets 100mg, serving international markets with regulatory-compliant medicines. Our major export regions include:
- Africa: Nigeria, Kenya, Uganda, South Africa, Tanzania
- Middle East: UAE, Saudi Arabia, Oman, Yemen
- Latin America: Brazil, Mexico, Chile, Argentina
- Asia-Pacific: Vietnam, Sri Lanka, Bangladesh, Philippines
We provide full regulatory documentation, ensuring smooth export and procurement processes.
Bedaquiline Tablets PCD Pharma Franchise Opportunities
We offer lucrative opportunities for PCD Pharma franchise partners across India. Distributors, wholesalers, and healthcare entrepreneurs can partner with us to distribute Bedaquiline Tablets 100mg (Hamsen) under the Taj Pharma brand.
Franchise Benefits:
- Monopoly rights in allocated territories
- Affordable pricing with high profit margins
- Marketing and promotional support
- WHO-GMP certified products ensuring trust and credibility
Why Taj Pharma is the #1 Bedaquiline Tablets Manufacturer in India
- Trusted Brand: Recognized by hospitals, NGOs, and government agencies
- Regulatory Compliance: WHO-GMP and ISO certifications
- Global Presence: Strong exports to Africa, Middle East, and Latin America
- Competitive Pricing: Affordable yet high-quality medicines
- Research-Driven: Continuous innovation in anti-TB drug development
Our mission is to ensure that patients battling MDR-TB worldwide have access to safe, effective, and affordable treatment options.
Taj Pharma India is the leading manufacturer, supplier, and exporter of Bedaquiline Tablets 100mg (Hamsen) in India. With world-class manufacturing in Vapi, Gujarat, distribution from Mumbai, Maharashtra, and a global supply chain, we are committed to fighting multidrug-resistant tuberculosis through innovation, quality, and affordability.
